Evaluating Hospital Readmissions for Persons With Serious and Complex Illness: A Competing Risks Approach.
Peter MayMelissa M GarridoEgidio Del FabbroDanielle NoreikaCharles NormandNevena SkoroJ Brian CasselPublished in: Medical care research and review : MCRR (2019)
Hospital readmission rate is a ubiquitous measure of efficiency and quality. Individuals with life-limiting illnesses account heavily for admissions but evaluation is complicated by high-mortality rates. We report a retrospective cohort study examining the association between palliative care (PC) and readmissions while controlling for postdischarge mortality with a competing risks approach. Eligible participants were adult inpatients admitted to an academic, safety-net medical center (2009-2015) with at least one diagnosis of cancer, heart failure, chronic obstructive pulmonary disease, liver failure, kidney failure, AIDS/HIV, and selected neurodegenerative conditions. PC was associated with reduced 30-, 60-, and 90-day readmissions (subhazard ratios = 0.57, 0.53, and 0.52, respectively [all p < .001]). Hospital PC is associated with a reduction in readmissions, and this is not explained by higher mortality among PC patients. Performance measures only counting those alive at a given end point may underestimate systematically the effects of treatments with a high-mortality rate.
Keyphrases
- cardiovascular events
- heart failure
- chronic obstructive pulmonary disease
- palliative care
- liver failure
- end stage renal disease
- healthcare
- risk factors
- antiretroviral therapy
- hepatitis b virus
- chronic kidney disease
- ejection fraction
- acute care
- newly diagnosed
- adverse drug
- human health
- emergency department
- human immunodeficiency virus
- peritoneal dialysis
- squamous cell carcinoma
- cardiovascular disease
- type diabetes
- papillary thyroid
- hiv infected
- risk assessment
- left ventricular
- advanced cancer
- prognostic factors
- childhood cancer
- south africa
- hiv testing
- drug induced